Iovance Biotherapeutics, Inc., a US-based biotechnology company focused on innovating, developing, and delivering novel ...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
Japan-based FunPep and Crafton Biotechnology have entered into a joint research agreement and commenced collaborative re...
M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a gl...
SCIEX, a Danaher company and leader in life science analytical technologies, has launched the novus V55 system - a next-...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Waters Corporation has announced that the BD BACTEC FXI Culture System has received US Food and Drug Administr...
3billion, a South Korea-based AI-powered genomic diagnostics company, has announced the launch of 3B-NEO, a premium...
MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Japan-based startup Toregem BioPharma has raised approximately $5.3 million (JPY 850 million) in Pre-Series C financing ...
Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...
US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologic...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
South Korea-based medtech innovator SKIA has announced that the US Food and Drug Administration (FDA) has gran...
Japan-based Meiji Seika Pharma Co. has committed to invest in the Global Health Security Fund (GHSF), which is sponsored...
This year’s meeting highlighted a dramatic shift in the geography of cancer drug development. Long viewed as &ldqu...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
What were the key takeaways for Hongene after attending TIDES USA 2026? TIDES USA 2026 reinforced several themes that w...
We’re seeing China move much more aggressively to bring innovative therapies beyond its borders. From your vantage...
